Erika B-Cure Laser Ltd (BCUR.TA)

ILA 20.3

(5.18%)

Market Cap (In ILA)

21.14 Million

Revenue (In ILA)

29.88 Million

Net Income (In ILA)

-19.22 Million

Avg. Volume

31.92 Thousand

Currency
ILA
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
16.9-45.0
PE
-2.03
EPS
-0.1
Beta Value
1.45
ISIN
IL0011789125
CUSIP
-
CIK
-
Shares
104165000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Moti Navon
Employee Count
-
Website
https://bcurelaser.com
Ipo Date
2021-08-01
Details
Erika B-Cure Laser Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It offers B-Cure Laser Classic, a home medical device for the treatment of pain, orthopedic problems, dermatology, analgesia, inflammation, and wound healing; and B-Cure Laser Pro, a device for the treatment of acute and chronic problems, such as orthopedic problems, diabetic wounds, and difficulties in healing and mucositis. The company also provides B-Cure Laser Sport, a home device for treating injuries and sports pain, orthopedics, and others; and B-Cure Laser Sport Pro, a professional device for treating sports injuries, and pain relief in areas of the body and muscles, as well as infections, including Achilles tendonitis. In addition, it offers B-Cure Laser Dental, a device for use in dental clinics to treat dental problems, relieve gum pain, and inflammation, as well as helps in the recovery process after dental treatment, including implants, and in reducing pain and swelling; and B-Pro Dental Laser Cure, a device for the treatment of dental problems and infections in dental clinics. The company was formerly known as Erica Carmel Ltd and changed its name to Erika B-Cure Laser Ltd in January 2022. Erika B-Cure Laser Ltd was incorporated in 2007 and is headquartered in Haifa, Israel.